Ocean Biomedical, Inc. 8-K Report: Stock and Warrant Insights for Investors
Based on the provided section of the financial report, here are the key insights and information extracted:
- Entity Information:
- Company Name: Ocean Biomedical, Inc.
- CIK Number: 0001869974
- Address: 55 Claverick St. Room 325, Providence, RI 02903
- Phone Number: (401) 444-7375
- SEC Filing Type: 8-K
- Filing Date: February 11, 2025
- Stock Information:
- Common Stock:
- Par Value: $0.0001
- Ticker Symbol: OCEA
- Exchange: NASDAQ
- Warrants:
- Description: Each warrant is exercisable for one share of common stock at an exercise price of $11.50.
- Ticker Symbol: OCEAW
- Exchange: NASDAQ
- Financial Context:
- Reporting Period: The report is as of February 11, 2025.
- Measurement Units:
- Currency: USD
- Shares: The report includes metrics related to shares.
- Segments:
- The report identifies two segments:
- Common Stock: Identified as "CommonStock0.0001ParValueMember".
- Warrants: Identified as "WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member".
- Regulatory References:
- The report is compliant with the XBRL (eXtensible Business Reporting Language) format, which is used for financial reporting.
Summary Insights:
- Ocean Biomedical, Inc. is actively traded on NASDAQ under the ticker symbols OCEA for common stock and OCEAW for warrants.
- The company has a low par value for its common stock, indicating a potentially high volume of shares issued.
- The warrants provide a future investment opportunity at a specified exercise price, which could impact stock dilution if exercised.
- This report is part of the company's ongoing compliance with SEC regulations and provides pertinent information for investors regarding its equity structure.
Overall, this filing may be relevant for investors assessing the company's capital structure and potential investment opportunities.